<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Combined Diffusion-Weighted, Blood Oxygen Level–Dependent, and Dynamic Contrast-Enhanced MRI for Characterization and Differentiation of Renal Cell Carcinoma" /><meta property="og:locale" content="en" /><meta name="description" content="Purpose" /><meta property="og:description" content="Purpose" /><link rel="canonical" href="https://clinicaltree.github.io/posts/combined-diffusion-weighted-blood-oxygen-level-dependent-and-dynamic-contrast-enhanced-mri-for-cha/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/combined-diffusion-weighted-blood-oxygen-level-dependent-and-dynamic-contrast-enhanced-mri-for-cha/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2013-05-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Combined Diffusion-Weighted, Blood Oxygen Level–Dependent, and Dynamic Contrast-Enhanced MRI for Characterization and Differentiation of Renal Cell Carcinoma" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2013-05-31T17:00:00+00:00","description":"Purpose","headline":"Combined Diffusion-Weighted, Blood Oxygen Level–Dependent, and Dynamic Contrast-Enhanced MRI for Characterization and Differentiation of Renal Cell Carcinoma","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/combined-diffusion-weighted-blood-oxygen-level-dependent-and-dynamic-contrast-enhanced-mri-for-cha/"},"url":"https://clinicaltree.github.io/posts/combined-diffusion-weighted-blood-oxygen-level-dependent-and-dynamic-contrast-enhanced-mri-for-cha/"}</script><title>Combined Diffusion-Weighted, Blood Oxygen Level–Dependent, and Dynamic Contrast-Enhanced MRI for Characterization and Differentiation of Renal Cell Carcinoma | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Combined Diffusion-Weighted, Blood Oxygen Level–Dependent, and Dynamic Contrast-Enhanced MRI for Characterization and Differentiation of Renal Cell Carcinoma</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Combined Diffusion-Weighted, Blood Oxygen Level–Dependent, and Dynamic Contrast-Enhanced MRI for Characterization and Differentiation of Renal Cell Carcinoma</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1370019600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> May 31, 2013 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Mike Notohamiprodjo MD</a> </em>, <em> <a href="">Michael Staehler MD</a> </em>, <em> <a href="">Nicole Steiner MD</a> </em>, <em> <a href="">Felix Schwab PhD</a> </em>, <em> <a href="">Steven P. Sourbron PhD</a> </em>, <em> <a href="">Henrik J. Michaely MD</a> </em>, <em> <a href="">Andreas D. Helck MD</a> </em>, <em> <a href="">Maximilian F. Reiser MD</a> </em>, <em> <a href="">Konstantin Nikolaou MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2221 words"> <em>12 min</em> read</span></div></div></div><div class="post-content"><h2 id="purpose"><span class="mr-2">Purpose</span><a href="#purpose" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To investigate a multiparametric magnetic resonance imaging (MRI) approach comprising diffusion-weighted imaging (DWI), blood oxygen–dependent (BOLD), and dynamic contrast-enhanced (DCE) MRI for characterization and differentiation of primary renal cell carcinoma (RCC).</p><h2 id="material-and-methods"><span class="mr-2">Material and Methods</span><a href="#material-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Fourteen patients with clear-cell carcinoma and four patients with papillary RCC were examined with DWI, BOLD MRI, and DCE MRI at 1.5T. The apparent diffusion coefficient (ADC) was calculated with a monoexponential decay. The spin-dephasing rate R2* was derived from parametric R2* maps. DCE-MRI was analyzed using a two-compartment exchange model allowing separation of perfusion (plasma flow [F P ] and plasma volume [V P ]), permeability (permeability surface area product [PS]), and extravascular extracellular volume (V E ). Statistical analysis was performed with Wilcoxon signed-rank test, Pearson’s correlation coefficient, and receiver operating characteristic curve analysis.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Clear-cell RCC showed higher ADC and lower R2* compared to papillary subtypes, but differences were not significant. F P of clear-cell subtypes was significantly higher than in papillary RCC. Perfusion parameters showed moderate but significant inverse correlation with R2*. V E showed moderate inverse correlation with ADC. F p and V p showed best sensitivity for histological differentiation.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Multiparametric MRI comprising DWI, BOLD, and DCE MRI is feasible for assessment of primary RCC. BOLD moderately correlates to DCE MRI–derived perfusion. ADC shows moderate correlation to the extracellular volume, but does not correlate to tumor oxygenation or perfusion. In this preliminary study DCE-MRI appeared superior to BOLD and DWI for histological differentiation.</p><p>Renal cell carcinoma (RCC) is the most common solid tumor of the kidney . Surgical excision (eg, total or partial nephrectomy) has been the long-standing sole therapy. With the advent of novel therapeutic agents, such as agents targeting the tyrosine kinase (TK) receptors of vascular endothelial growth factor or mammalian target of rapamycin (mTOR) , a more detailed diagnosis of RCC and differentiation of RCC subtypes has become of increasing interest. Apart from recent developments such as novel phase mask filters and newer nanosized contrast agents , functional magnetic resonance imaging (MRI) techniques such as dynamic contrast-enhanced (DCE) MRI and diffusion-weighted imaging (DWI) have been applied for characterization of tumor tissue and separation of tumor subtypes. DCE MRI assesses the transit of gadolinium derivates through the tissue as a function of time. By applying physical models, information on perfusion and permeability can be derived, which may serve as biomarkers towards antiangiogenic therapies . DWI exploits the random walk of water molecules as an endogenous contrast agent . The apparent diffusion coefficient (ADC) serves as a potentially convenient, but ambiguous measure on cellularity and perfusion and has been proposed as biological marker for tumor biology and treatment response .</p><p>Tumor oxygen levels are also an auspicious biological marker in oncology because low oxygenation levels have been shown to be linked to therapy failure and poor patient outcome . Blood oxygen level–dependent (BOLD) MRI is the only method to noninvasively assess the tissue oxygen content. It uses the paramagnetic effect of deoxyhemoglobin for indirect depiction of renal oxygenation . The concentration of deoxyhemoglobin increases with rising oxygen consumption, leading to a decreasing T2* relaxation time of the surrounding tissue. The spin dephasing rate R2* is therefore an index of the oxygenation of tissue (R2* = 1/T2*). BOLD MRI has been shown to be useful for evaluation of parenchymal kidney diseases, such as renal artery stenosis , and correlates with renal tumor histology or grade . In other tumor entities such as breast cancer, BOLD MRI provided complementary information to DCE MRI , as does BOLD MRI and DWI for the assessment of diabetic nephropathy .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="material-and-methods-1"><span class="mr-2">Material and methods</span><a href="#material-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-subjects"><span class="mr-2">Study Subjects</span><a href="#study-subjects" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging"><span class="mr-2">Imaging</span><a href="#imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="dwi"><span class="mr-2">DWI</span><a href="#dwi" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="bold"><span class="mr-2">BOLD</span><a href="#bold" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="dce-mri"><span class="mr-2">DCE MRI</span><a href="#dce-mri" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="postprocessing"><span class="mr-2">Postprocessing</span><a href="#postprocessing" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="pathology"><span class="mr-2">Pathology</span><a href="#pathology" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>t=r×n−2√1−r2√ t</p><p>=</p><p>r</p><p>×</p><p>n</p><p>−</p><p>2</p><p>1</p><p>−</p><p>r</p><p>2</p><p>In which df = degrees of freedom; <em>n</em> = number of pairs of data; and <em>r</em> = correlation coefficient.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="morphology-and-histology"><span class="mr-2">Morphology and Histology</span><a href="#morphology-and-histology" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Morphologic Information of Assessed Tumors</p><p>Morphology Size (cm) Necrosis Homogeneity Clear cell 5.6 ± 2.5 2 2 Papillary 4.1 ± 1.4 0 3 T1 signal Hypointense Isointense Hyperintense Clear cell 4 8 2 Papillary 2 1 1 T2 signal Hypointense Isointense Hyperintense Clear cell 3 6 5 Papillary 1 1 2 Enhancement Hypointense Isointense Hyperintense Clear cell 6 2 6 Papillary 3 1 0</p><p>Tumor signal intensity was compared to renal cortex.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="functional-analysis"><span class="mr-2">Functional Analysis</span><a href="#functional-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Results of Functional Parameters Derived from DWI (ADC), BOLD (R2*), and DCE MRI (F P , V P , V E , PS)</p><p>Histology ADC mm 2 /second R2* seconds −1 F P mL/100 mL/min V P mL/100 mL V E mL/100 mL PS mL/100 mL/min Clear cell</p><p><em>n</em> = 12 1.45 ± 0.16 14.2 ± 7.5 189.1 ± 126.4 ∗ 36.5 ± 23.9 9.2 ± 9.4 3.4 ± 5.4 Papillary</p><p><em>n</em> = 4 1.28 ± 0.15 21.7 ± 10.9 21.1 ± 16.4 10.01 ± 10.3 9.5 ± 1.7 1.8 ± 0.2 Necrotic</p><p><em>n</em> = 2 1.76 ± 0.07 5.3 ± 1.2 NA NA NA NA</p><p>ADC, apparent diffusion coefficient; BOLD, blood oxygen–dependent; DCE, dynamic contrast-enhanced; DWI, diffusion-weighted imaging; F P , plasma flow; MRI, magnetic resonance imaging; NA, not available; PS, permeability surface area product; R2*, spin-dephasing rate; V E , extravascular extracellular volume; V P , plasma volume.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/0_1s20S1076633213000378.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/0_1s20S1076633213000378.jpg" alt="Figure 1, Highly perfused clear cell carcinoma. A 62-year-old female patient with clear-cell renal cell carcinoma of the right lower pole ( arrow ). The tumor is highly perfused (plasma flow [F P ]: 400 mL/100 mL/minute). R2* is relatively low (7.7 seconds −1 ), suggesting rich oxygen supply, whereas apparent diffusion coefficient (ADC) is relatively high (1.7 mm 2s), suggesting a relatively low cellularity. FLASH 3D, three-dimensional fast low angle shot; R2*, spin-dephasing rate." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/1_1s20S1076633213000378.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/1_1s20S1076633213000378.jpg" alt="Figure 2, Clear carcinoma with intermediate perfusion. A 56-year-old male patient with clear cell renal cell carcinoma of the left kidney hilus ( arrow ). The tumor shows intermediate perfusion (plasma flow [F P ] 113 mL/100 mL/min) and a moderately high R2*(18.3 seconds −1 ) and apparent diffusion coefficient (ADC; 1.45 mm 2second). F P , plasma flow; HASTE, half-Fourier single-shot turbo-spin-echo; R2*, spin-dephasing rate." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/2_1s20S1076633213000378.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/2_1s20S1076633213000378.jpg" alt="Figure 3, Hypoperfused papillary renal cell carcinoma (RCC). A 52-year-old female patient with papillary RCC of the left lower kidney pole ( arrow ). The tumor is hypoperfused (F P 12.5 mL/100 mL/minute) and displays a low apparent diffusion coefficient (ADC) of 1.1 mm 2second, indicating high cellularity. BOLD MRI shows a high spin dephasing rate R2*(33 ms −1 ), suggesting hypoxia of the tumor. FLASH 3D, three-dimensional fast low angle shot; F P , plasma flow; R2*, spin-dephasing rate." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="correlation-of-functional-mri-parameters"><span class="mr-2">Correlation of Functional MRI Parameters</span><a href="#correlation-of-functional-mri-parameters" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Correlation of Functional MRI Parameters</p><p>R2* F P V P V E PS R2* 1 −0.67 † −0.73 † 0.20 0.18 ADC 0.18 0.34 0.42 −0.57 † 0.24</p><p>ADC, apparent diffusion coefficient; F P , plasma flow; MRI, magnetic resonance imaging; PS, permeability surface area product; R2*, spin-dephasing rate; V E , extravascular extracellular volume; V P , plasma volume.</p><p>Correlation was calculated with Pearson’s correlation coefficient.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/3_1s20S1076633213000378.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/3_1s20S1076633213000378.jpg" alt="Figure 4, Correlation of the different techniques. Scatter plots for plasma flow/spin-dephasing rate (R2*) ( r = −0.67), plasma volume/R2* ( r = −0. 73), and apparent diffusion coefficient/extracellular volume ( r = −0.52). There was a significant correlation ( P &lt; .01), respectively." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="roc-curve-analysis"><span class="mr-2">ROC Curve Analysis</span><a href="#roc-curve-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Receiver Operator Characteristic Analysis of Functional MRI Parameters</p><p>Threshold AUC SE Sensitivity (%) Specificity (%) CI 95% R2* 12.1 seconds −1 0.688 0.139 100 33 0.415–0.960 ADC 1.1 mm 2 /second 0.854 0.037 100 50 0.781–0.927 F P 21 mL/100 mL/min 0.979 0.068 100 75 0.846–1.000 V P 10 mL/100 mL 0.938 0.034 100 75 0.871–1.000 PS NA 0.646 0.114 NA NA 0.422–0.870 V E NA 0.375 0.120 NA NA 0.140–0.610</p><p>ADC, apparent diffusion coefficient; AUC, area under the curve; F P , plasma flow; NA, not available; MRI, magnetic resonance imaging; PS, permeability surface area product; R2*, spin-dephasing rate; SE, standard error; V E , extravascular extracellular volume; V P , plasma volume.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/4_1s20S1076633213000378.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CombinedDiffusionWeightedBloodOxygenLevelDependentandDynamicContrastEnhancedMRIforCharacterizationandDifferentiationofRenalCellCarcinoma/4_1s20S1076633213000378.jpg" alt="Figure 5, Receiver operating characteristic (ROC) curve analysis. ROC curve analysis for differentiation between clear cell and papillary RCC for plasma flow, plasma volume, PS, extracellular volume, apparent diffusion coefficient (ADC), and spin-dephasing rate (R2*). The straight diagonal line spanning the middle of the graph indicates an area under the curve (AUC) of 0.5." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="results-of-the-single-modalities"><span class="mr-2">Results of the Single Modalities</span><a href="#results-of-the-single-modalities" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="correlation-of-the-techniques"><span class="mr-2">Correlation of the Techniques</span><a href="#correlation-of-the-techniques" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Staehler M., Rohrmann K., Haseke N., et. al.: Targeted agents for the treatment of advanced renal cell carcinoma. Curr Drug Targets 2005; 6: pp. 835-846.</p><li><p>2. Casciaro S., Bianco R., Franchini R., et. al.: A new automatic phase mask filter for high-resolution brain venography at 3 T: theoretical background and experimental validation. Magnet Res Imaging 2010; 28: pp. 511-519.</p><li><p>3. Malvindi M.A., Greco A., Conversano F., et. al.: Magnetic/silica nanocomposites as dual-mode contrast agents for combined magnetic resonance imaging and ultrasonography. Adv Funct Materials 2011; 21: pp. 2548-2555.</p><li><p>4. Notohamiprodjo M., Sourbron S., Staehler M., et. al.: Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study. J Magnet Res Imaging 2010; 31: pp. 490-501.</p><li><p>5. Notohamiprodjo M., Pederson M., Glaser C., et. al.: Comparison of Gd-DTPA and Gd-BOPTA for studying renal perfusion and filtration. J Magnet Res Imaging 2011; 34: pp. 595-607.</p><li><p>6. Wang H., Cheng L., Zhang X., et. al.: Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology 2010; 257: pp. 135-143.</p><li><p>7. Notohamiprodjo M., Glaser C., Herrmann K.A., et. al.: Diffusion tensor imaging of the kidney with parallel imaging: initial clinical experience. Invest Radiol 2008; 43: pp. 677-685.</p><li><p>8. Saremi F., Sefidbakht S., Quane L., et. al.: Effect of intravenous extracellular gadolinium based contrast medium on renal diffusion weighted images. Acad Radiol 2011; 18: pp. 174-183.</p><li><p>9. Notohamiprodjo M., Reiser M.F., Sourbron S.P.: Diffusion and perfusion of the kidney. Eur J Radiol 2010; 76: pp. 337-347.</p><li><p>10. Notohamiprodjo M., Dietrich O., Horger W., et. al.: Diffusion tensor imaging (DTI) of the kidney at 3 tesla-feasibility, protocol evaluation and comparison to 1.5 Tesla. Invest Radiol 2010; 45: pp. 245-254.</p><li><p>11. Padhani A.R., Khan A.A.: Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol 2010; 5: pp. 39-52.</p><li><p>12. Pacheco-Torres J., Lopez-Larrubia P., Ballesteros P., et. al.: Imaging tumor hypoxia by magnetic resonance methods. NMR Biomed 2011; 24: pp. 1-16.</p><li><p>13. Textor S.C., Glockner J.F., Lerman L.O., et. al.: The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008; 19: pp. 780-788.</p><li><p>14. Min J.H., Kim C.K., Park B.K., et. al.: Assessment of renal lesions with blood oxygenation level-dependent MRI at 3 T: preliminary experience. AJR Am J Roentgenol 2011; 197: pp. W489-W494.</p><li><p>15. Chen J., Ding J., Wu C., et. al.: Preoperatively evaluating the correlation between pathological grades and blood oxygenation level-dependent MRI in clear cell renal cell carcinomas. Acad Radiol 2012; 20: pp. 224-230.</p><li><p>16. Baudelet C., Cron G.O., Gallez B.: Determination of the maturity and functionality of tumor vasculature by MRI: correlation between BOLD-MRI and DCE-MRI using P792 in experimental fibrosarcoma tumors. Magnet Res Med 2006; 56: pp. 1041-1049.</p><li><p>17. Ries M., Basseau F., Tyndal B., et. al.: Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magnet Res Imaging 2003; 17: pp. 104-113.</p><li><p>18. Attenberger U.I., Sourbron S.P., Michaely H.J., et. al.: Retrospective respiratory triggering renal perfusion MRI. Acta Radiol 2010; 51: pp. 1163-1171.</p><li><p>19. Eng J.: Teaching receiver operating characteristic analysis: an interactive laboratory exercise. Acad Radiol 2012; 19: pp. 1452-1456.</p><li><p>20. Dujardin M., Sourbron S., Luypaert R., et. al.: Quantification of renal perfusion and function on a voxel-byvoxel basis: a feasibility study. Magn Reson Med 2005; 54: pp. 841-849.</p><li><p>21. Eng J.: Sampling the latest work in receiver operating characteristic analysis: what does it mean?. Acad Radiol 2012; 19: pp. 1449-1451.</p><li><p>22. Dutcher J.P., de Souza P., McDermott D., et. al.: Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies. Med Oncol 2009; 26: pp. 202-209.</p><li><p>23. Flaherty K.T., Rosen M.A., Heitjan F.H., et. al.: Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma. Cancer Biol Ther 2008; 7: pp. 496-501.</p><li><p>24. Taouli B., Thakur R.K., Mannelli L., et. al.: Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 2009; 251: pp. 398-407.</p><li><p>25. Le Bihan D., Breton E., Lallemand D., et. al.: MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: pp. 401-407.</p><li><p>26. Chandarana H., Lee V.S., Hecht E., et. al.: Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Inves Radiol 2011; 46: pp. 285-291.</p><li><p>27. Tofts P.S., Brix G., Buckley D.L., et. al.: Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: pp. 223-232.</p><li><p>28. Sourbron S.P., Buckley D.L.: On the scope and interpretation of the Tofts models for DCE-MRI. Magnet Res Med 2011; 66: pp. 735-745.</p><li><p>29. Donaldson S.B., West C.M., Davidson S.E., et. al.: A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix. Magnet Res Med 2010; 63: pp. 691-700.</p><li><p>30. Luypaert R., Sourbron S., de Mey J.: Validity of perfusion parameters obtained using the modified Tofts model: a simulation study. Magnet Res Med 2011; 65: pp. 1491-1497.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-20/'>Volume 20</a>, <a href='/categories/issue-6/'>Issue 6</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Combined%20Diffusion-Weighted,%20Blood%20Oxygen%20Level%E2%80%93Dependent,%20and%20Dynamic%20Contrast-Enhanced%20MRI%20for%20Characterization%20and%20Differentiation%20of%20Renal%20Cell%20Carcinoma%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcombined-diffusion-weighted-blood-oxygen-level-dependent-and-dynamic-contrast-enhanced-mri-for-cha%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Combined%20Diffusion-Weighted,%20Blood%20Oxygen%20Level%E2%80%93Dependent,%20and%20Dynamic%20Contrast-Enhanced%20MRI%20for%20Characterization%20and%20Differentiation%20of%20Renal%20Cell%20Carcinoma%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcombined-diffusion-weighted-blood-oxygen-level-dependent-and-dynamic-contrast-enhanced-mri-for-cha%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcombined-diffusion-weighted-blood-oxygen-level-dependent-and-dynamic-contrast-enhanced-mri-for-cha%2F&text=Combined%20Diffusion-Weighted,%20Blood%20Oxygen%20Level%E2%80%93Dependent,%20and%20Dynamic%20Contrast-Enhanced%20MRI%20for%20Characterization%20and%20Differentiation%20of%20Renal%20Cell%20Carcinoma%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/assessing-splenomegaly/"><div class="card-body"> <em class="small" data-ts="1370019600" data-df="ll" > May 31, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Assessing Splenomegaly</h3><div class="text-muted small"><p> Rationale and Objectives To define systematic volumetric thresholds to identify and grade splenomegaly and retrospectively evaluate the performance of radiologists to assess splenomegaly in comput...</p></div></div></a></div><div class="card"> <a href="/posts/comparison-of-3d-phase-sensitive-inversion-recovery-and-2d-inversion-recovery-mri-at-3-0-t-for-the-a/"><div class="card-body"> <em class="small" data-ts="1370019600" data-df="ll" > May 31, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Comparison of 3D Phase-Sensitive Inversion-Recovery and 2D Inversion-Recovery MRI at 3.0 T for the Assessment of Late Gadolinium Enhancement in Patients with Hypertrophic Cardiomyopathy</h3><div class="text-muted small"><p> Rationale and Objectives To compare free-breathing three-dimensional (3D) phase-sensitive inversion recovery (PSIR) with breath-holding two-dimensional (2D) IR sequences to determine which is bett...</p></div></div></a></div><div class="card"> <a href="/posts/debates-dialectic-and-rhetoric/"><div class="card-body"> <em class="small" data-ts="1370019600" data-df="ll" > May 31, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Debates, Dialectic, and Rhetoric</h3><div class="text-muted small"><p> Arguing is an art and essential to the functioning of our political and legal system. Moderated debates between residents are a useful educational vehicle to teach residents health economics and he...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/assessing-splenomegaly/" class="btn btn-outline-primary" prompt="Older"><p>Assessing Splenomegaly</p></a> <a href="/posts/comparison-of-3d-phase-sensitive-inversion-recovery-and-2d-inversion-recovery-mri-at-3-0-t-for-the-a/" class="btn btn-outline-primary" prompt="Newer"><p>Comparison of 3D Phase-Sensitive Inversion-Recovery and 2D Inversion-Recovery MRI at 3.0 T for the Assessment of Late Gadolinium Enhancement in Patients with Hypertrophic Cardiomyopathy</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
